American Indian Law Review

Oliva Gibbs LLP Welcomes Professor Christopher Kulander

Retrieved on: 
Monday, November 13, 2023
Fulbright Program, Oil, Learning, OG, Geology, Student, Doctor of Philosophy, Petroleum, OGU, Teaching, University, Specialization, American Indian Law Review, Management, Nursing, Science, Counsel

HOUSTON, Nov. 13, 2023 /PRNewswire-PRWeb/ -- Oliva Gibbs is delighted to announce the addition of Professor Christopher Kulander as Of Counsel at the firm. Professor Kulander teaches energy and property law courses at the South Texas College of Law – Houston and currently serves as Director of the school's Oil & Gas Law Institute. His primary focus will be to further build out Oliva Gibbs University (OGU), which is the firm's dedicated educational and leadership initiative. OGU content is aimed at advancing legal and business knowledge to foster professional growth within the organization and beyond.

Key Points: 
  • Oliva Gibbs welcomes Professor Christopher Kulander to enhance their educational initiative, Oliva Gibbs University (OGU), leveraging his expertise in energy and property law as well as his role as Director of the Oil & Gas Law Institute at South Texas College of Law – Houston.
  • HOUSTON, Nov. 13, 2023 /PRNewswire-PRWeb/ -- Oliva Gibbs is delighted to announce the addition of Professor Christopher Kulander as Of Counsel at the firm.
  • "I could not be more excited to welcome Professor Kulander to the OG team," said partner Brad Gibbs .
  • Professor Kulander noted that working with Oliva Gibbs would provide a unique and compelling opportunity to combine his passion for legal education with the ability to work on interesting and complex oil and gas matters.

Robins Kaplan LLP Announces Major Proposed Opioid Settlement for Its Tribal Nation Clients

Retrieved on: 
Tuesday, November 15, 2022
Legal, Professional Services, Walmart, Cardinal Health, State attorney general, American Indians, Cardinal, Janssen Pharmaceuticals, Johnson & Johnson, AmerisourceBergen, Purdon, Multidistrict litigation, Party, State, Robins Kaplan LLP, Public International Law & Policy Group, Bankruptcy, Country, McKesson Corporation, Lawyer, Policy, Silicon, American Indian Law Review, Pharmaceutical industry, Tribe

Robins Kaplan LLP announced a proposed $77.9 million settlement of the pending national opioid litigation claims by Tribes brought against Wal-Mart.

Key Points: 
  • Robins Kaplan LLP announced a proposed $77.9 million settlement of the pending national opioid litigation claims by Tribes brought against Wal-Mart.
  • The proposed settlement, which must be agreed to by the sovereign governments of the Tribes, is the latest major settlement of Tribal opioid claims in the Ohio-based federal Multi-District Litigation.
  • The Wal-Mart settlement moves the total amount of opioid settlement and possible bankruptcy court payment dollars to Tribes to well over $1,000,000,000.
  • The court-appointed Tribal Leadership Committee on which Robins Kaplan LLP serves and Wal-Mart are in the process of drafting definitive settlement agreements.

Robins Kaplan LLP Announces Proposed Opioid Settlement for Its Tribal Nation Clients

Retrieved on: 
Tuesday, February 1, 2022
Legal, Professional Services, State attorney general, McKesson Corporation, Multidistrict litigation, Janssen Pharmaceuticals, State, Johnson & Johnson, Centers for Disease Control and Prevention, Exercise, Eastern Pequot Tribal Nation, American Indian Law Review, Center, AmerisourceBergen, Janssen, Robins Kaplan LLP, Purdon, Drug overdose, Public International Law & Policy Group, Policy, History, Distributor, Pharmaceutical industry, Tribe, Tribe

Robins Kaplan LLP announces a proposed $439 million settlement of the national opioid litigation claims by Tribes brought against AmerisourceBergen Corp., McKesson Corp., Cardinal Health, Inc (Distributors) and a proposed $150 million settlement of the national opioid litigation claims by Tribes brought against Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. N/K/A Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., N/K/A Janssen Pharmaceuticals, Inc. (Janssen).

Key Points: 
  • Robins Kaplan LLP announces a proposed $439 million settlement of the national opioid litigation claims by Tribes brought against AmerisourceBergen Corp., McKesson Corp., Cardinal Health, Inc (Distributors) and a proposed $150 million settlement of the national opioid litigation claims by Tribes brought against Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. N/K/A Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., N/K/A Janssen Pharmaceuticals, Inc. (Janssen).
  • Janssen has agreed to resolve the Tribal claims for $150,000,000, payable over two years.
  • Given this, the dollars that will flow to Tribes under this initial settlement will help fund crucial, on-reservation, culturally appropriate opioid treatment services.
  • The court appointed Tribal Leadership Committee on which Robins Kaplan LLP serves and the settling Defendants have entered into settlement Term Sheets summarizing their agreements and are in the process of drafting definitive settlement agreements.